We gather weekly the most important Vaping news.
INTERNATIONAL REGULATION
NICE AND PHE PUBLISH COMPREHENSIVE DRAFT GUIDELINE TO TACKLE THE HEALTH BURDEN OF SMOKING
Healthcare staff should give clear and up-to-date information on e-cigarettes to people who are interested in using them to stop smoking, according to draft NICE guideline recommendations out for consultation today. NICE worked with Public Health England to develop this guideline
WASHINGTON, DC COUNCIL VOTES TO BAN FLAVORED VAPING PRODUCTS
On June 29, the Washington, DC Council voted to ban the sale of flavored tobacco products—a designation that includes vapes as well as menthol cigarettes.
OPINIONS
CAN INDIA LOOK FOR SAFER NICOTINE PRODUCTS?
Very few want to accept that public health will not be served nor lives saved by a war on nicotine, as doomed to failure as the war on drugs. The WHO must refocus its efforts on supporting a billion plus adult smokers to quit by all available means.
ACHIEVING SMOKEFREE 2025 GOAL WILL BE COSTLY. THE ALTERNATIVE IS MUCH COSTLIER
This year almost 5,000 New Zealanders will die from smoking cigarettes. As many as two in three adult smokers will die from smoking, losing on average about 10 years of life – a staggering toll.
SCIENTIFIC REPORTS
STUDY EXAMINES HOW FLAVORED E-CIGARETTES MAY DISTINCTLY AFFECT THE BRAIN
Researchers at Penn State University examined how flavored e-cigarettes may distinctly affect the brain compared to non-flavored ones.
STUDY OFFERS A NEW MODEL FOR EXAMINING GENETIC RISK ASSOCIATED WITH NICOTINE DEPENDENCE
Higher polygenetic scores for a risk for schizophrenia, depression, neuroticism, self-reported risk-taking, a high body mass index, alcohol use disorder, along a higher number of cigarettes smoked per day were all indicators of a higher risk for nicotine dependence, the study found.
STORY OF THE WEEK
E-CIGARETTES MORE HELPFUL THAN NICOTINE REPLACEMENT TREATMENTS FOR DEPENDENT SMOKERS
E-cigarettes are more effective than nicotine replacement treatments in achieving long term smoking reduction and cessation, according to the results of a clinical trial by Queen Mary University of London.
